Merck Focuses Resources on Core Activities

Shorter drug development cycles, better cost efficiency, and an increased focus on internal resources are key changes being implemented by Merck’s manufacturing division to respond to challenges facing the pharma industry, says Willie A. Deese, president/manufacturing division at Merck. Deese, who holds responsibility for Merck’s global manufacturing, procurement, and operational excellence functions, spoke at Socma’s luncheon during DCAT week in New York last week. “We’re not changing our business model and our approach to R&D...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers